Learn more

HAEMOPEP PHARMA GMBH

Overview
  • Total Patents
    26
About

HAEMOPEP PHARMA GMBH has a total of 26 patent applications. Its first patent ever was published in 1990. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are FORSSMANN WOLF GEORG, APITOPE TECHNOLOGY BRISTOL LTD and EXOCELL INC.

Patent filings per year

Chart showing HAEMOPEP PHARMA GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Forssmann Wolf-Georg 22
#2 Raida Manfred 7
#3 Adermann Knut 7
#4 Staendker Ludger 5
#5 Schulz-Knappe Peter 4
#6 Fluege Thomas 4
#7 Von Eickstedt Klaus-Wolf 3
#8 Herbst Franz 3
#9 Zucht Hans-Dieter 3
#10 Nier Volker 2

Latest patents

Publication Filing date Title
US2011263509A1 Preparation and use of high-purity hemoparatide (hpth-1-37) for the treatment of inflammatory scaling diseases of the skin
WO2008059066A1 New chemokine derivatives of ccl14, synthesis and use as drugs for the treatment of allergic diseases
DE10023665A1 New human virus-inhibiting peptide, useful e.g. for treating viral or other infections or cancer, comprises fragment of alpha1-antitrypsin
WO0017240A1 Hmw endostatin for inhibiting the growth of tumours and capillary proliferation and for diagnosing vascular and tumour diseases
DE19906921A1 New neuronal cell survival factor, useful for treatment and diagnosis of neuronal diseases, e.g. Alzheimer's disease
DE19801438A1 Use of phosphodiesterase (PDE) inhibitors to improve sperm motility in insemination and in-vitro fertilization procedures
US6579849B2 Antibiotic peptides from bovine milk
AU5334296A Antibiotic peptides from bovine milk
US5744444A HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof
WO9528952A1 Use of brain natriuretic peptides (bnp), phosphorylated urodilatine, phosphorylated cdd/anp and combinations thereof
EP0756491A1 Use of brain natriuretic peptides (bnp), phosphorylated urodilatine, phosphorylated cdd/anp and combinations thereof